Viewing Study NCT03755102

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-03-03 @ 4:34 AM
Study NCT ID: NCT03755102
Status: COMPLETED
Last Update Posted: 2025-05-15
First Post: 2018-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None EGFR Gene Mutation View
None Lung Cancer View
None Lung Cancer Metastatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EGFR C797S View
None EGFR mutant lung cancer View
None dacomitinib View
None osimertinib View
None 18-341 View
None Memorial Sloan Kettering Cancer Center View